entrectinib has been researched along with Breast-Neoplasms* in 1 studies
1 other study(ies) available for entrectinib and Breast-Neoplasms
Article | Year |
---|---|
TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.
NTRK gene fusions are rare oncogenic driver mutations that can be found in a broad range of neoplasms. In secretory carcinoma (SC), Topics: Benzamides; Breast Neoplasms; Carcinoma; Gene Fusion; Humans; Indazoles | 2022 |